Innodata(INOD) - 2025 Q3 - Quarterly Results

Financial Performance - Revenue for Q3 2025 reached $62.6 million, representing a 20% year-over-year organic revenue growth[3] - Adjusted EBITDA for Q3 2025 was $16.2 million, an increase of 17% from $13.9 million in the same period last year[3] - Net income for Q3 2025 was $8.3 million, or $0.26 per basic share, compared to $17.4 million, or $0.60 per basic share, in the same period last year[3] - Adjusted EBITDA for the nine months ended September 30, 2025, was $42.2 million, an increase of 106% from $20.4 million in the same period last year[3] - Consolidated net income for the nine months ended September 30, 2025, was $23,348 million, compared to $18,372 million for the same period in 2024, reflecting a growth of 27.5%[28] - Adjusted Gross Profit for the three months ended September 30, 2025, was $27,677 million, a 21.5% increase from $22,887 million in 2024[30] - Total revenue for the nine months ended September 30, 2025, was $179,287,000, compared to $111,281,000 for the same period in 2024, marking a 60.9% increase[34] - Adjusted EBITDA for the nine months ended September 30, 2025, was $42,164,000, significantly higher than $20,427,000 in 2024[32] Cash and Investments - Cash, cash equivalents, and short-term investments totaled $73.9 million as of September 30, 2025, up from $46.9 million as of December 31, 2024[3] - Cash and cash equivalents as of September 30, 2025, rose to $73,859 million, compared to $46,897 million at the end of 2024, marking a 57.4% increase[26] - The company reported a net cash provided by operating activities of $33,871 million for the nine months ended September 30, 2025, compared to $17,684 million in 2024, indicating a significant increase of 91.1%[28] Growth Projections - The company anticipates 45% or more year-over-year organic revenue growth in 2025, with transformative growth expected in 2026[6] - The company has reiterated guidance for continued transformative growth based on new wins and strong momentum[6] Segment Performance - DDS segment revenue for the three months ended September 30, 2025, reached $54,779,000, a 22.6% increase compared to $44,694,000 in 2024[34] - The DDS segment's net income for the nine months ended September 30, 2025, was $23,464,000, compared to $16,492,000 in 2024, reflecting a 42.2% increase[32] - Synodex segment reported a net loss of $44,000 for the three months ended September 30, 2025, compared to a profit of $381,000 in the same period of 2024[32] - Agility segment adjusted EBITDA for the three months ended September 30, 2025, was $854,000, a decrease from $1,236,000 in the prior year[32] - The Synodex segment's adjusted EBITDA for the nine months ended September 30, 2025, was $1,012,000, down from $1,515,000 in 2024[32] Assets and Liabilities - Total assets increased to $152,916 million as of September 30, 2025, up from $113,449 million at the end of 2024, representing a growth of 34.7%[26] - The total liabilities as of September 30, 2025, were $55,676 million, compared to $50,060 million at the end of 2024, reflecting a rise of 11.3%[26] Stock-Based Compensation - Stock-based compensation for the consolidated entity increased to $8,309,000 for the nine months ended September 30, 2025, from $2,881,000 in the same period of 2024[32]